Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

0.4372 -0.1072 (-19.69%)
Delayed Quote Updated: 10:55 AM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Fractyl Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Company will discuss recent corporate updates, including compelling preclinical data from Rejuva® pancreatic gene therapy platform, which was named top abstract at American Diabetes Association’s 84th... 
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
Management to host in-person KOL event and webcast at ADA on Monday, June 24, 2024, at 7:00 a.m. ET 
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024 ↗
GUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
The 3 Most Volatile Stocks for Short-Term Traders: April 2024 ↗
Volatile stocks, as measured by their beta, offer short-term traders quick profit prospects whether the stock soars or nosedives. 
Via InvestorPlace
News headline image
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. 
Via Benzinga
News headline image
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. 
Via Benzinga
News headline image
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
News headline image
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data ↗
Fractyl Health unveils RJVA-001, a groundbreaking GLP-1 gene therapy for metabolic diseases. Promising preclinical results show durable blood sugar and weight reduction in diabetes mouse model. 
Via Benzinga
News headline image
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday! 
Via InvestorPlace
News headline image
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Maker Of Wilson Tennis Rackets Raises $1.37 Billion In Discounted IPO ↗
Amer Sports, the maker of Wilson tennis rackets and a host of other sports equipment, raised about $1.37 billion in its initial public offering, which was priced below the previously expected $16-$18... 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.